BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Stem cell
,
Human chorionic gonadotropin
,
Fluoxetine
,
rs2230926
,
DRD2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyclin- dependent kinase
Summary
General Info
Curated Studies
Most Correlated Studies
T cell acute lymphoblastic leukemia MOLT4 cells treated with cyclin-dependent kinase inhibitors
Cyclin D1 and CDK4 contribute to the undifferentiated phenotype in neuroblastoma
Embryonic stem cells, fibroblasts and brain tissues from cyclin C knockout mouse embryos
NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
Prostate cancer cell line (LNCaP) treated with trichostatin A or roscovitine, or EZH2 knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Host CDK-1 and formin mediate microvillar effacement induced by enterohemorrhagic Escherichia coli.
Compartmentalized control of Cdk1 drives mitotic spindle assembly.
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of p…
PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions.
Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colo…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Adva…
Evaluation of Skin Health and Quality of Life in Patients Receiving Anti-PD1/PDL1/CTLA4 or Cyclin-de…
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ